We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLS
7376
DELISTED
Apellis Pharmaceuticals
APLS
$247K ﹤0.01%
+11,267
New +$259K
BIS icon
7377
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$2.32M
$247K ﹤0.01%
1,588
-437
-22% -$72.7K
ORAN
7378
CALL
DELISTED
Orange
ORAN
$247K ﹤0.01%
+14,800
New +$258K
DBKO
7379
DELISTED
Xtrackers MSCI South Korea Hedged Equity ETF
DBKO
$247K ﹤0.01%
8,540
-19,676
-70% -$609K
SYNT
7380
CALL
DELISTED
Syntel Inc
SYNT
$247K ﹤0.01%
7,700
-1,900
-20% -$56.8K
SBIO icon
7381
CALL
ALPS Medical Breakthroughs ETF
SBIO
$201M
$246K ﹤0.01%
6,600
-1,600
-20% -$58K
SLP icon
7382
Simulations Plus
SLP
$369M
$246K ﹤0.01%
+11,049
New +$209K
XNET
7383
CALL
Xunlei
XNET
$340M
$246K ﹤0.01%
23,000
-10,000
-30% -$124K
ZOES
7384
CALL
DELISTED
Zoe's Kitchen, Inc.
ZOES
$246K ﹤0.01%
25,200
-15,100
-37% -$192K
DMC
7385
Del Monte Corp
DMC
$1.41B
$245K ﹤0.01%
5,507
-28,061
-84% -$1.31M
IMUX icon
7386
Immunic
IMUX
$190M
$245K ﹤0.01%
+89
New +$206K
KNDI
7387
CALL
Kandi Technologies Group
KNDI
$67.5M
$245K ﹤0.01%
57,700
+28,800
+100% +$145K
VHC icon
7388
CALL
VirnetX Holding Corp
VHC
$54.4M
$245K ﹤0.01%
3,605
-475
-12% -$30.9K
BAL
7389
CALL
DELISTED
iPath Series B Bloomberg Cotton Subindex Total ReturnSM ETN
BAL
$245K ﹤0.01%
+4,700
New +$248K
SXCP
7390
CALL
DELISTED
SunCoke Energy Partners, L.P.
SXCP
$245K ﹤0.01%
16,300
+6,000
+58% +$97.3K
HZNP
7391
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$245K ﹤0.01%
14,793
-174,589
-92% -$2.66M
BSM icon
7392
PUT
Black Stone Minerals
BSM
$3.18B
$244K ﹤0.01%
+13,200
New +$237K
EPP icon
7393
PUT
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
$244K ﹤0.01%
+5,300
New +$250K
ING icon
7394
ING
ING
$99.8B
$244K ﹤0.01%
17,030
-409,167
-96% -$6.5M
PINC
7395
PUT
DELISTED
Premier
PINC
$244K ﹤0.01%
+6,700
New +$222K
ECHO
7396
CALL
EchoStar
ECHO
$24.4B
$244K ﹤0.01%
+6,787
New +$277K
VRNT
7397
PUT
DELISTED
Verint Systems
VRNT
$244K ﹤0.01%
10,797
-11,385
-51% -$248K
MDRX
7398
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$244K ﹤0.01%
20,300
+2,100
+12% +$25.9K
OCLR
7399
CALL
DELISTED
Oclaro Inc.
OCLR
$244K ﹤0.01%
27,300
-15,800
-37% -$138K
ATRC icon
7400
CALL
AtriCure
ATRC
$1.92B
$243K ﹤0.01%
+9,000
New +$212K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.